BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 14770184)

  • 1. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.
    Helgadottir A; Manolescu A; Thorleifsson G; Gretarsdottir S; Jonsdottir H; Thorsteinsdottir U; Samani NJ; Gudmundsson G; Grant SF; Thorgeirsson G; Sveinbjornsdottir S; Valdimarsson EM; Matthiasson SE; Johannsson H; Gudmundsdottir O; Gurney ME; Sainz J; Thorhallsdottir M; Andresdottir M; Frigge ML; Topol EJ; Kong A; Gudnason V; Hakonarson H; Gulcher JR; Stefansson K
    Nat Genet; 2004 Mar; 36(3):233-9. PubMed ID: 14770184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Lipoxygenase activating protein (ALOX5AP): association with cardiovascular infarction and stroke.
    Ben-Asher E; Lancet D
    Isr Med Assoc J; 2004 May; 6(5):318-9. PubMed ID: 15151378
    [No Abstract]   [Full Text] [Related]  

  • 3. PDE4D and ALOX5AP genetic variants and risk for Ischemic Cerebrovascular Disease in Sweden.
    Kostulas K; Gretarsdottir S; Kostulas V; Manolescu A; Helgadottir A; Thorleifsson G; Gudmundsson LJ; Thorsteinsdottir U; Gulcher JR; Stefansson K; Hillert J
    J Neurol Sci; 2007 Dec; 263(1-2):113-7. PubMed ID: 17655870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart disease. Gene suggests asthma drugs may ease cardiovascular inflammation.
    Wickelgren I
    Science; 2004 Feb; 303(5660):941. PubMed ID: 14963296
    [No Abstract]   [Full Text] [Related]  

  • 5. ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study.
    Girelli D; Martinelli N; Trabetti E; Olivieri O; Cavallari U; Malerba G; Busti F; Friso S; Pizzolo F; Pignatti PF; Corrocher R
    Eur J Hum Genet; 2007 Sep; 15(9):959-66. PubMed ID: 17505527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis.
    Zintzaras E; Rodopoulou P; Sakellaridis N
    Am J Epidemiol; 2009 Mar; 169(5):523-32. PubMed ID: 19126581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population.
    Linsel-Nitschke P; Götz A; Medack A; König IR; Bruse P; Lieb W; Mayer B; Stark K; Hengstenberg C; Fischer M; Baessler A; Ziegler A; Schunkert H; Erdmann J
    Clin Sci (Lond); 2008 Nov; 115(10):309-15. PubMed ID: 18318662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach.
    Zee RY; Cheng S; Hegener HH; Erlich HA; Ridker PM
    Stroke; 2006 Aug; 37(8):2007-11. PubMed ID: 16778124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene B4 production in healthy subjects carrying variants of the arachidonate 5-lipoxygenase-activating protein gene associated with a risk of myocardial infarction.
    Maznyczka A; Mangino M; Whittaker A; Braund P; Palmer T; Tobin M; Goodall AH; Bradding P; Samani NJ
    Clin Sci (Lond); 2007 Jun; 112(7):411-6. PubMed ID: 17176247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study.
    Domingues-Montanari S; Fernández-Cadenas I; del Rio-Espinola A; Corbeto N; Krug T; Manso H; Gouveia L; Sobral J; Mendioroz M; Fernández-Morales J; Alvarez-Sabin J; Ribó M; Rubiera M; Obach V; Martí-Fàbregas J; Freijo M; Serena J; Ferro JM; Vicente AM; Oliveira SA; Montaner J
    Cerebrovasc Dis; 2010; 29(6):528-37. PubMed ID: 20357438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic and radiation hybrid mapping of human arachidonate 5-lipoxygenase-activating protein (ALOX5AP) to chromosome 13q12.
    Yandava CN; Kennedy BP; Pillari A; Duncan AM; Drazen JM
    Genomics; 1999 Feb; 56(1):131-3. PubMed ID: 10036194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients.
    Lõhmussaar E; Gschwendtner A; Mueller JC; Org T; Wichmann E; Hamann G; Meitinger T; Dichgans M
    Stroke; 2005 Apr; 36(4):731-6. PubMed ID: 15731479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidate genes of the 5-lipoxygenase pathway in acute coronary syndrome: a pilot study.
    Wung SF; Aouizerat BE
    Biol Res Nurs; 2008 Apr; 9(4):280-92. PubMed ID: 18398223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.
    Wahlstrand B; Orho-Melander M; Delling L; Kjeldsen S; Narkiewicz K; Almgren P; Hedner T; Melander O
    J Hypertens; 2009 Apr; 27(4):769-73. PubMed ID: 19293724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial.
    Hakonarson H; Thorvaldsson S; Helgadottir A; Gudbjartsson D; Zink F; Andresdottir M; Manolescu A; Arnar DO; Andersen K; Sigurdsson A; Thorgeirsson G; Jonsson A; Agnarsson U; Bjornsdottir H; Gottskalksson G; Einarsson A; Gudmundsdottir H; Adalsteinsdottir AE; Gudmundsson K; Kristjansson K; Hardarson T; Kristinsson A; Topol EJ; Gulcher J; Kong A; Gurney M; Thorgeirsson G; Stefansson K
    JAMA; 2005 May; 293(18):2245-56. PubMed ID: 15886380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
    Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
    Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.
    Gretarsdottir S; Thorleifsson G; Reynisdottir ST; Manolescu A; Jonsdottir S; Jonsdottir T; Gudmundsdottir T; Bjarnadottir SM; Einarsson OB; Gudjonsdottir HM; Hawkins M; Gudmundsson G; Gudmundsdottir H; Andrason H; Gudmundsdottir AS; Sigurdardottir M; Chou TT; Nahmias J; Goss S; Sveinbjörnsdottir S; Valdimarsson EM; Jakobsson F; Agnarsson U; Gudnason V; Thorgeirsson G; Fingerle J; Gurney M; Gudbjartsson D; Frigge ML; Kong A; Stefansson K; Gulcher JR
    Nat Genet; 2003 Oct; 35(2):131-8. PubMed ID: 14517540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region.
    Lövkvist H; Smith JG; Luthman H; Höglund P; Norrving B; Kristoffersson U; Jönsson AC; Lindgren AG
    Eur J Hum Genet; 2008 Sep; 16(9):1117-25. PubMed ID: 18398440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population.
    Helgadottir A; Gretarsdottir S; St Clair D; Manolescu A; Cheung J; Thorleifsson G; Pasdar A; Grant SF; Whalley LJ; Hakonarson H; Thorsteinsdottir U; Kong A; Gulcher J; Stefansson K; MacLeod MJ
    Am J Hum Genet; 2005 Mar; 76(3):505-9. PubMed ID: 15640973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polymorphic variants of ALOX5AP gene and the risk of acute stroke development in the Russian population].
    Bondarenko EA; Slominskiĭ PA; Limborskaia SA; Shetova IM; Timofeev DY; Skvortsova VI
    Genetika; 2011 Apr; 47(4):570-3. PubMed ID: 21675249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.